niflumic acid has been researched along with Ache in 9 studies
Niflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Percutaneously administered niflumic acid gel (Niflugel R, Laboratories UPSA, Rueil Malmaison, France) was compared to placebo in a double blind, placebo controlled, multicentre study in the treatment of acute upper and lower limb tendinitis." | 9.07 | A double blind, placebo controlled study of niflumic acid gel in the treatment of acute tendinitis. ( Charlot, J; Ditisheim, A; Dreiser, RL; Lopez, A, 1991) |
| "Morniflumate has a 30-year history of clinical use, particularly for the treatment of pain associated with paediatric ENT infection." | 6.52 | Efficacy and safety of morniflumate for the treatment of symptoms associated with soft tissue inflammation. ( Cavalieri, L; Cremonesi, G, 2015) |
| "Percutaneously administered niflumic acid gel (Niflugel R, Laboratories UPSA, Rueil Malmaison, France) was compared to placebo in a double blind, placebo controlled, multicentre study in the treatment of acute upper and lower limb tendinitis." | 5.07 | A double blind, placebo controlled study of niflumic acid gel in the treatment of acute tendinitis. ( Charlot, J; Ditisheim, A; Dreiser, RL; Lopez, A, 1991) |
| " Adverse drug reactions may be renal, gastrointestinal, hematological, or immunologic." | 2.82 | Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years. ( Gorenflo, M; Saur, P; van den Anker, JN; van Dyk, M; Welzel, T; Ziesenitz, VC, 2022) |
| "Morniflumate has a 30-year history of clinical use, particularly for the treatment of pain associated with paediatric ENT infection." | 2.52 | Efficacy and safety of morniflumate for the treatment of symptoms associated with soft tissue inflammation. ( Cavalieri, L; Cremonesi, G, 2015) |
| "Additional experiments on thermal hyperalgesia in wild-type and mClca3 knock-out mice in the first 3 days of AIA did not show a difference either." | 1.40 | Does chloride channel accessory 3 have a role in arthritis pain? A study on murine antigen-induced arthritis. ( Ebbinghaus, M; Gajda, M; Holtzman, MJ; Schaible, HG; Schulz, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Vivier, D | 1 |
| Bennis, K | 1 |
| Lesage, F | 1 |
| Ducki, S | 1 |
| Ziesenitz, VC | 1 |
| Welzel, T | 1 |
| van Dyk, M | 1 |
| Saur, P | 1 |
| Gorenflo, M | 1 |
| van den Anker, JN | 1 |
| Ebbinghaus, M | 1 |
| Gajda, M | 1 |
| Holtzman, MJ | 1 |
| Schulz, S | 1 |
| Schaible, HG | 1 |
| Cremonesi, G | 1 |
| Cavalieri, L | 1 |
| Pacheco, Dda F | 1 |
| Pacheco, CM | 1 |
| Duarte, ID | 1 |
| Lapalle, H | 1 |
| Bouron, Y | 1 |
| Romanet, P | 1 |
| Krakovits, G | 1 |
| Tallián, A | 1 |
| Képes, P | 1 |
| Danysz, A | 1 |
| Dreiser, RL | 1 |
| Ditisheim, A | 1 |
| Charlot, J | 1 |
| Lopez, A | 1 |
4 reviews available for niflumic acid and Ache
| Article | Year |
|---|---|
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Struc | 2016 |
Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.
Topics: Adolescent; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; C | 2022 |
Efficacy and safety of morniflumate for the treatment of symptoms associated with soft tissue inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Hum | 2015 |
[Niflumic acid].
Topics: Animals; Anti-Inflammatory Agents; Dogs; Drug Evaluation; Drug Evaluation, Preclinical; Fever; Human | 1975 |
2 trials available for niflumic acid and Ache
| Article | Year |
|---|---|
Clinical effectivity of Donalgin--niflumic acid--in locomotor diseases.
Topics: Aminopyrine; Arthritis; Clinical Trials as Topic; Drug Combinations; Humans; Joint Diseases; Movemen | 1981 |
A double blind, placebo controlled study of niflumic acid gel in the treatment of acute tendinitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Double-Blind Method; Female; Gels; Humans; Male; Middle Aged | 1991 |
3 other studies available for niflumic acid and Ache
| Article | Year |
|---|---|
Does chloride channel accessory 3 have a role in arthritis pain? A study on murine antigen-induced arthritis.
Topics: Animals; Arthritis; Chloride Channels; Freund's Adjuvant; Ganglia, Spinal; Hot Temperature; Hyperalg | 2014 |
δ-Opioid receptor agonist SNC80 induces central antinociception mediated by Ca2+ -activated Cl- channels.
Topics: Analgesics, Opioid; Animals; Benzamides; Benzomorphans; Calcium; Cations; Chloride Channels; Enkepha | 2012 |
[The mucocutaneous lymph node syndrome. Report of one case].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Child, Preschool; Conjunctivitis; Co | 1978 |